Psychiatric Times articleshttps://www.psychiatrictimes.com/newsPsychiatric Times articles© 2026 MJH Life Sciences™ and Psychiatric Times. All rights reserved.Sat, 22 Aug 2026 08:16:39 +00005en-us14447https://www.psychiatrictimes.com/newshttps://www.psychiatrictimes.com/logo.webphttps://www.psychiatrictimes.com/view/cultural-competency-and-community-engagement-in-psychiatric-practicehttps://www.psychiatrictimes.com/view/cultural-competency-and-community-engagement-in-psychiatric-practice<![CDATA[Learn how community-based supports, clinician self-reflection, and culturally responsive systems close mental health gaps beyond the clinic.]]>Fri, 21 Aug 2026 19:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/kratom-component-in-clinical-trial-for-opioid-use-disorderhttps://www.psychiatrictimes.com/view/kratom-component-in-clinical-trial-for-opioid-use-disorder<![CDATA[FDA acceptance of mitragynine IND launches NIH phase 1 trial for opioid use disorder, tracking safety, dosing, and PK amid new DEA scheduling moves.]]>Fri, 21 Aug 2026 15:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/digital-amnesia-and-why-print-should-be-prizedhttps://www.psychiatrictimes.com/view/digital-amnesia-and-why-print-should-be-prized<![CDATA[Digital reading boosts convenience but weakens comprehension and memory; evidence links “digital amnesia” to shallower learning, making print vital for deep clinical study.]]>Fri, 21 Aug 2026 14:30:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/brain-function-biomarker-testing-in-psychiatry-with-universal-brain-eeghttps://www.psychiatrictimes.com/view/brain-function-biomarker-testing-in-psychiatry-with-universal-brain-eeg<![CDATA[UBP EEG system turns quick clinic recordings into scalable brain biomarkers to guide depression treatment and advance objective psychiatry care.]]>Fri, 21 Aug 2026 14:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/nida-awards-pleopharma-6-5-million-grant-to-advance-phase-3-trial-of-pp-01-for-cannabis-use-disorderhttps://www.psychiatrictimes.com/view/nida-awards-pleopharma-6-5-million-grant-to-advance-phase-3-trial-of-pp-01-for-cannabis-use-disorder<![CDATA[PleoPharma secures $6.5M NIDA grant to advance phase 3 PP-01 trial, aiming to ease cannabis withdrawal and address untreated cannabis use disorder.]]>Thu, 20 Aug 2026 19:23:40 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/why-cultural-context-matters-in-psychiatric-assessmenthttps://www.psychiatrictimes.com/view/why-cultural-context-matters-in-psychiatric-assessment<![CDATA[Why care improves when clinicians ask about housing, work, money and access—using culturally responsive tools to uncover hidden stressors.]]>Thu, 20 Aug 2026 19:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/podcast-integrative-approaches-to-chronic-pain-with-julia-rodes-mdhttps://www.psychiatrictimes.com/view/podcast-integrative-approaches-to-chronic-pain-with-julia-rodes-md<![CDATA[A paraplegic psychiatry resident shares integrative chronic pain care: ACT, spinal stimulation, and goals focused on function, not pain scores.]]>Thu, 20 Aug 2026 16:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/a-practical-role-for-long-acting-buprenorphine-in-opioid-use-disorder-carehttps://www.psychiatrictimes.com/view/a-practical-role-for-long-acting-buprenorphine-in-opioid-use-disorder-care<![CDATA[Long-acting injectable buprenorphine cuts missed doses, boosts retention, and protects patients during high-risk transitions in the fentanyl era.]]>Thu, 20 Aug 2026 14:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/objective-measurement-for-psychiatry-universal-brain-s-erp-systemhttps://www.psychiatrictimes.com/view/objective-measurement-for-psychiatry-universal-brain-s-erp-system<![CDATA[ A new system for dry EEG measurement expands imaging options for psychiatry.]]>Thu, 20 Aug 2026 14:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/fda-feedback-paves-way-for-new-ind-filing-for-pt00114-in-generalized-anxiety-disorderhttps://www.psychiatrictimes.com/view/fda-feedback-paves-way-for-new-ind-filing-for-pt00114-in-generalized-anxiety-disorder<![CDATA[FDA signals clear IND path for PT00114, a first-in-class neuropeptide aiming to reset stress responses in patients with generalized anxiety disorder.]]>Thu, 20 Aug 2026 13:19:33 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/asking-about-identity-a-collaborative-approach-to-patient-carehttps://www.psychiatrictimes.com/view/asking-about-identity-a-collaborative-approach-to-patient-care<![CDATA[Learn how psychiatrists ask about identity with curiosity, transparency, and cultural humility—building trust, reducing assumptions, and shaping culturally informed treatment plans.]]>Wed, 19 Aug 2026 15:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/lets-talk-about-drug-testinghttps://www.psychiatrictimes.com/view/lets-talk-about-drug-testing<![CDATA[Urine drug screenings are often misordered and misread, risking stigma and harm; learn immunoassay limits, confirmatory testing basics, and when testing truly helps.]]>Wed, 19 Aug 2026 14:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/neuropsychiatry-in-the-news-wearable-technology-for-parkinson-disease-ecopipam-for-tourette-syndromehttps://www.psychiatrictimes.com/view/neuropsychiatry-in-the-news-wearable-technology-for-parkinson-disease-ecopipam-for-tourette-syndrome<![CDATA[FDA clears a Parkinson disease wearable and fast-tracks ecopipam for pediatric Tourette syndrome, showing advances in neuropsychiatric care.]]>Wed, 19 Aug 2026 13:20:16 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/psyched-perspectives-adhd-in-underrecognized-populations-with-paige-walton-mdhttps://www.psychiatrictimes.com/view/psyched-perspectives-adhd-in-underrecognized-populations-with-paige-walton-md<![CDATA[Learn more about ADHD across populations in this podcast episode.]]>Wed, 19 Aug 2026 13:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/update-on-varenicline-for-smoking-cessation-in-patients-with-bipolar-disorderhttps://www.psychiatrictimes.com/view/update-on-varenicline-for-smoking-cessation-in-patients-with-bipolar-disorder<![CDATA[Learn why varenicline leads smoking cessation products in bipolar disorder, with reassuring safety data and practical strategies when quitting proves difficult.]]>Tue, 18 Aug 2026 14:11:26 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/hlp003-deuterated-psilocin-as-an-adjunctive-therapy-for-major-depressive-disorderhttps://www.psychiatrictimes.com/view/hlp003-deuterated-psilocin-as-an-adjunctive-therapy-for-major-depressive-disorder<![CDATA[HLP003, a deuterated psilocin agonist, enters phase 3 as an add-on for MDD, aiming to boost SSRI/SNRI response earlier.]]>Mon, 17 Aug 2026 17:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/home-based-tdcs-for-depression-expanding-access-to-neuromodulation-treatmenthttps://www.psychiatrictimes.com/view/home-based-tdcs-for-depression-expanding-access-to-neuromodulation-treatment<![CDATA[Remote, home-based tDCS shows modest symptom relief and higher remission in major depression, with generally good safety but burn risks to watch.]]>Mon, 17 Aug 2026 15:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/morning-rounds-news-from-august-10-16https://www.psychiatrictimes.com/view/morning-rounds-news-from-august-10-16<![CDATA[A quick recap of the last week in psychiatric news.]]>Mon, 17 Aug 2026 14:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/fda-approves-tauklarify-mk-6240-for-tau-pathology-detection-in-alzheimer-diseasehttps://www.psychiatrictimes.com/view/fda-approves-tauklarify-mk-6240-for-tau-pathology-detection-in-alzheimer-disease<![CDATA[FDA approves PET imaging agent for Alzheimer disease tau pathology.]]>Fri, 14 Aug 2026 15:20:03 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/experience-with-xanomeline-trospium-in-an-acute-inpatient-setting-treating-individuals-with-schizophreniahttps://www.psychiatrictimes.com/view/experience-with-xanomeline-trospium-in-an-acute-inpatient-setting-treating-individuals-with-schizophrenia<![CDATA[Real‑world inpatient use of xanomeline/trospium shows rapid awakening from negative symptoms in schizophrenia, with response predictors and striking case insights.]]>Thu, 13 Aug 2026 14:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/podcast-exploring-entactogens-with-hiroe-imai-hu-do-and-james-w-murrough-md-phdhttps://www.psychiatrictimes.com/view/podcast-exploring-entactogens-with-hiroe-imai-hu-do-and-james-w-murrough-md-phd<![CDATA[Entactogen research targets social anxiety and isolation across diagnoses, pairing “plasticity windows” with psychotherapy amid shifting FDA scrutiny and evolving trial designs.]]>Thu, 13 Aug 2026 13:05:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/entactogens-as-a-new-frontier-for-mood-and-anxiety-disordershttps://www.psychiatrictimes.com/view/entactogens-as-a-new-frontier-for-mood-and-anxiety-disorders<![CDATA[Experts weigh MDMA-like entactogens for social anxiety and depression, neuroplasticity windows, and what FDA setbacks mean for next-wave treatments.]]>Thu, 13 Aug 2026 13:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/the-night-we-heard-ella-singhttps://www.psychiatrictimes.com/view/the-night-we-heard-ella-sing<![CDATA["...time slowed to the tide’s rhythm and the surf’s roar, each day closed by a Great Horned Owl’s silent fly-by at dusk..." ]]>Thu, 13 Aug 2026 13:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/phase-4-trial-of-viloxazine-er-shows-real-world-gains-for-adhd-with-comorbid-depression-anxietyhttps://www.psychiatrictimes.com/view/phase-4-trial-of-viloxazine-er-shows-real-world-gains-for-adhd-with-comorbid-depression-anxiety<![CDATA[New data on viloxazine ER (Qelbree) show improvements in ADHD, depression, and anxiety in adults, including those who use nicotine or cannabis.]]>Wed, 12 Aug 2026 22:09:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/new-ingrezza-data-shows-improved-quality-of-life-and-daily-functioning-in-tardive-dyskinesiahttps://www.psychiatrictimes.com/view/new-ingrezza-data-shows-improved-quality-of-life-and-daily-functioning-in-tardive-dyskinesia<![CDATA[KINECT-PRO shows Ingrezza eases tardive dyskinesia movements and boosts daily function and quality of life, even across psychiatric diagnoses.]]>Wed, 12 Aug 2026 15:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/dt120-lysergide-shows-rapid-lasting-relief-for-generalized-anxiety-in-phase-3-trialhttps://www.psychiatrictimes.com/view/dt120-lysergide-shows-rapid-lasting-relief-for-generalized-anxiety-in-phase-3-trial<![CDATA[DT120 (lysergide) hits all endpoints in phase 3 GAD trial, cutting anxiety scores with a single dose.]]>Wed, 12 Aug 2026 13:15:33 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/resuscitating-the-biopsychosocial-model-in-psychiatryhttps://www.psychiatrictimes.com/view/resuscitating-the-biopsychosocial-model-in-psychiatry<![CDATA[Why modern psychiatry risks missing the person: It's time to revive biopsychosocial, cultural, and spiritual history beyond DSM checklists and EHR bloat.]]>Wed, 12 Aug 2026 13:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/brain-trust-carl-salzman-md-on-benzodiazepine-mindful-prescribing-misuse-and-dependencehttps://www.psychiatrictimes.com/view/brain-trust-carl-salzman-md-on-benzodiazepine-mindful-prescribing-misuse-and-dependence<![CDATA[Experts unpack when benzodiazepines help or harm, tapering myths, older-adult risks, and why Alzheimer links may be overstated.]]>Wed, 12 Aug 2026 13:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/trd-matching-patients-to-the-right-treatmenthttps://www.psychiatrictimes.com/view/trd-matching-patients-to-the-right-treatment<![CDATA[Michael Thase, MD, explores evolving treatment strategies for treatment-resistant depression, including interventional psychiatry and emerging therapies.]]>Tue, 11 Aug 2026 19:05:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/new-ctx-1301-data-affirms-pharmacokinetic-profile-to-treat-adhdhttps://www.psychiatrictimes.com/view/new-ctx-1301-data-affirms-pharmacokinetic-profile-to-treat-adhd<![CDATA[New data show once-daily CTx-1301 delivers 3 timed dexmethylphenidate releases for faster onset, steadier late-day ADHD coverage, tolerability.]]>Tue, 11 Aug 2026 14:30:00 GMTPsychiatric TimesusPsychiatric Times Articles